The AR inhibitor fidarestat is effective as adjuvant therapy to enhance doxorubicin sensitivity of colorectal cancer cells and to reduce cardiotoxicity associated with the drug.
This slideshow reviews doxorubicin (Adriamycin), indicated for the treatment of acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, and non-Hodgkin lymphoma.
How should a fibrin overgrowth on an internal catheter be managed when there is no blood return from the implanted port?
Investigators have identified two compounds that appear to block the cardiac damage caused by doxorubicin. Their report indicates that inhibiting the action of an enzyme key to the generation of cellular energy in mitochondria could prevent doxorubicin-induced damage to cardiac cells without reducing the drug’s antitumor effects.
Doxorubicin accumulates within the mitochondria of cardiomyocytes and this accumulation promotes mitochondrial production of reactive oxygen species (ROS) and the accumulation of iron.
Oncology nursing literature states that a MUGA scan must be obtained prior to initiating cardiotoxic chemotherapies. When should the scan be obtained?
After expedited review, the FDA okays the first generic version of Doxil (doxorubicin hydrochloride liposome injection), now in short supply.
